Image

Oral Microbiome in Carotid Atherosclerosis

Oral Microbiome in Carotid Atherosclerosis

Recruiting
18 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this observational study, called OMICA (Oral Microbiome in Carotid Atherosclerosis), is to learn how bacteria living in the mouth may influence the development and stability of plaques in the carotid arteries, which supply blood to the brain. Plaque buildup in these arteries can lead to stroke.

Researchers want to understand whether certain oral bacteria are linked to plaque vulnerability, meaning a higher chance that the plaque will rupture and cause a stroke.

The study will include a cohort of adults scheduled for carotid endarterectomy at Semmelweis University. Participants will be enrolled in the Semmelweis University Carotid Biobank project.

The main questions the study aims to answer are:

Do people with more severe gum disease or tooth infection have a higher number of bacteria in their carotid plaques, and are those plaques more likely to rupture?

Are the bacteria found in vulnerable plaques different from those in stable plaques?

Are similar bacteria found in the mouth, gut, and plaques, suggesting that bacteria may travel through the body?

What participants will do:

Have their oral health checked before surgery, including an exam of gum disease and tooth infections.

Provide microbiome samples from the mouth, anus, urine, and carotid plaque (taken during surgery).

Have preoperative photon-counting computed tomography (CT) performed to assess plaque stability and study eligibility.

All samples and imaging data will be analyzed to identify bacterial species and their relationship to plaque type.

The study does not involve any experimental treatment or medication. Participation adds no significant medical risk beyond standard care.

Researchers will compare bacterial patterns between people with vulnerable plaques and those with stable plaques to identify microbial signatures linked to carotid plaque instability.

The results may help create future microbiome-based risk models for detecting people at higher risk of stroke or severe atherosclerosis.

Description

Background and Rationale: Cardiovascular diseases are currently the leading cause of death globally, according to the World Health Organization. Recent studies report a 4.2% prevalence of moderate to severe carotid artery stenosis. A growing body of evidence highlights the association between poor oral health and vascular disease. Periodontitis is a highly prevalent condition, affecting approximately 10% of the global population with its severe form (1). Several studies have revealed correlations between the severity of periodontal disease and the presence of pathogenic bacteria in carotid (2) and atherosclerotic plaques (3).

Methods

Population: The cross-sectional study includes a cohort of patients undergoing carotid endarterectomy: roughly half with vulnerable and half with stable carotid plaques. Photon-counting computed tomography (CTA) is part of the preoperative eligibility assessment confirming internal carotid artery stenosis and determining inclusion in the study. Only non-invasive magnetic resonance (MR) and ultrasound imaging will be requested from participants as part of the study protocol for classification of plaque vulnerability. All imaging data will be anonymized in accordance with Semmelweis University data protection protocols.

Intervention (Sample Collection): This study involves preoperative oral health evaluation and the collection of oral, anal, urine, blood, and carotid plaque samples during carotid endarterectomy for microbiome analysis. All samples and corresponding data will be fully anonymized and processed within the Semmelweis University Carotid Plaque Biobank (BM/33955-1/2023).

Comparator: Patients with vulnerable vs. stable carotid plaques, as classified by carotid duplex ultrasound (GSM score) and photon-counting CTA and MR plaque characterization.

Outcome
  1. Identification of periodontal and endodontic pathogens in the oral microbiome that positively correlate with plaque severity and vulnerability.
  2. Distinct microbiome compositions in carotid plaques of patients with stable versus vulnerable lesions, supporting the role of bacterial colonization in plaque instability.
  3. Detection of microbiome similarities across oral, anal, and vascular samples, suggesting systemic bacterial dissemination that may contribute to carotid stenosis progression.

Expected Value of Results: This project integrates microbiome and imaging data to explore links between oral bacteria and carotid plaque vulnerability. By investigating the interplay between oral microbiota and vascular disease, the study aims to deepen our understanding of plaque pathogenesis and progression. The findings may contribute to developing microbiome-based risk prediction models for plaque vulnerability, supported by advanced imaging data.

Eligibility

Inclusion Criteria:

  • Confirmed internal carotid artery (ICA) stenosis on preoperative photon-counting computed tomography (CTA)
  • Adults (≥18 years) undergoing carotid endarterectomy at Semmelweis University.
  • Eligible for surgery based on standard anesthesiologic evaluation.
  • Willing and able to provide written informed consent for participation and sample collection.

Exclusion Criteria:

  • Active systemic infection or current antibiotic therapy within 30 days before surgery.
  • Immunosuppressive therapy or immunodeficiency disorders.
  • Inability to undergo MRI (e.g., pacemaker, metallic implants, severe claustrophobia).
  • Pregnancy or lactation.
  • Malignancy under active treatment.
  • Prior carotid surgery or stenting on the same side.
  • Refusal or inability to provide informed consent.

Study details
    Atherosclerosis Cardiovascular Disease
    Atherosclerosis of Artery
    Carotid Artery Plaque
    Periodontitis
    Carotid Artery Diseases

NCT07296965

Semmelweis University Heart and Vascular Center

31 January 2026

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.